Use of recombinant erythropoietins in the setting of renal disease-Reference-Cited by-同舟云学术

Use of recombinant erythropoietins in the setting of renal disease

Published: Issue: Volume: Page:153-161
ISSN:
Container-title:Erythropoietins and Erythropoiesis
language:
Short-container-title:

Author:

Macdougall Iain C.

Publisher

Birkhäuser-Verlag

Link

http://link.springer.com/content/pdf/10.1007/3-7643-7543-4_9.pdf

Reference40 articles.

1. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316: 73–78

2. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW, Friedman EA, Graber SE, Haley NR et al. (1989) Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111: 992–1000

3. Sundal E, Kaeser U (1989) Correction of anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year’s treatment in a European multicentre study of 150 haemodialysis-dependent patients. Nephrol Dial Transplant 4: 979–987

4. Breen CP, Macdougall IC (1999) Correction of epoetin-resistant megaloblastic anaemia following vitamin B(12) and folate administration. Nephron 83: 374–375

5. Van Wyck DB (1989) Iron deficiency in patients with dialysis-associated anemia during erythropoietin replacement therapy: strategies for assessment and management. Semin Nephrol 9(suppl. 2): 21–24

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of c.577del in EPO : Investigations into endogenous EPO double‐band detected in blood with SAR‐PAGE;Drug Testing and Analysis;2021-11-22